Evidence map›Paper›PMID 27378816›Full record

ArticlePlant physiology2016

A Brachypodium UDP-Glycosyltransferase Confers Root Tolerance to Deoxynivalenol and Resistance to Fusarium Infection.

Jean-Claude Pasquet, Valentin Changenet, Catherine Macadré, Edouard Boex-Fontvieille, Camille Soulhat, Oumaya Bouchabké-Coussa, Marion Dalmais, Vessela Atanasova-Pénichon, Abdelhafid Bendahmane, Patrick Saindrenan and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Plant physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. The Analysis of the Glycosyltransferase Activity Gene Family inInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Evaluation ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Comparison of Antifungal Activity ofPlants (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Jean-Claude PasquetIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.
Valentin ChangenetIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.ORCID 0000-0001-5152-0768
Catherine MacadréIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.
Edouard Boex-FontvieilleIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.ORCID 0000-0001-7605-7474
Camille SoulhatIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.
Oumaya Bouchabké-CoussaIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.
Marion DalmaisIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.ORCID 0000-0002-1673-3095
Vessela Atanasova-PénichonIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.ORCID 0000-0002-4561-5493
Abdelhafid BendahmaneIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.
Patrick SaindrenanIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France.ORCID 0000-0002-4155-1314
Marie DufresneIPS2, UMR9213/UMR1403, CNRS, INRA, UPSud, UPD, SPS, 91405 Orsay, France;INRA, UMR1318, IJPB, RD10, F-78000 Versailles, France;APT, IJPB, RD10, F-78000 Versailles, France; andINRA/UR1264 MycSA, Domaine de la Grande-Ferrade CS20032, 33883 Villenave d'Ornon cedex, France marie.dufresne@u-psud.fr.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fusarium head blight (FHB) is a cereal disease caused by Fusarium graminearum, a fungus able to produce type B trichothecenes on cereals, including deoxynivalenol (DON), which is harmful for humans and animals. Resistance to FHB is quantitative, and the mechanisms underlying resistance are poorly understood. Resistance has been related to the ability to conjugate DON into a glucosylated form, deoxynivalenol-3-O-glucose (D3G), by secondary metabolism UDP-glucosyltransferases (UGTs). However, functional analyses have never been performed within a single host species. Here, using the model cereal species Brachypodium distachyon, we show that the Bradi5g03300 UGT converts DON into D3G in planta. We present evidence that a mutation in Bradi5g03300 increases root sensitivity to DON and the susceptibility of spikes to F. graminearum, while overexpression confers increased root tolerance to the mycotoxin and spike resistance to the fungus. The dynamics of expression and conjugation suggest that the speed of DON conjugation rather than the increase of D3G per se is a critical factor explaining the higher resistance of the overexpressing lines. A detached glumes assay showed that overexpression but not mutation of the Bradi5g03300 gene alters primary infection by F. graminearum, highlighting the involvement of DON in early steps of infection. Together, these results indicate that early and efficient UGT-mediated conjugation of DON is necessary and sufficient to establish resistance to primary infection by F. graminearum and highlight a novel strategy to promote FHB resistance in cereals.

Indexed as

Amino Acid SequenceBase SequenceBrachypodiumDisease ResistanceFusariumGene Expression Regulation, EnzymologicGene Expression Regulation, PlantGlucosidesGlycosyltransferasesHost-Pathogen InteractionsKineticsMutationPlant DiseasesPlant ProteinsPlant RootsPlants, Genetically Modifieddeoxynivalenoldeoxynivalenol-3-glucosideGlucosidesGlycosyltransferasesPlant ProteinsTrichothecenesUridine Diphosphate

Identifiers

PMID27378816
PMCPMC5074643
OpenAlexW2474913350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.